DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,468,000 | -81.5% | 367,121 | -77.3% | 0.01% | -83.6% |
| Q3 2019 | $7,916,000 | +78.8% | 1,615,417 | +112.0% | 0.06% | +89.7% |
| Q1 2019 | $4,428,000 | -39.7% | 762,146 | +39.6% | 0.03% | -45.3% |
| Q4 2018 | $7,348,000 | +28.6% | 545,948 | +85.4% | 0.05% | +103.8% |
| Q3 2018 | $5,715,000 | -25.5% | 294,444 | -1.9% | 0.03% | -25.7% |
| Q2 2018 | $7,673,000 | -35.8% | 300,183 | -49.4% | 0.04% | -30.0% |
| Q1 2018 | $11,945,000 | +192.6% | 592,819 | +200.7% | 0.05% | +212.5% |
| Q3 2017 | $4,083,000 | -67.1% | 197,171 | -76.5% | 0.02% | -68.6% |
| Q2 2017 | $12,394,000 | -60.1% | 837,450 | -57.0% | 0.05% | -64.8% |
| Q1 2017 | $31,061,000 | +718.5% | 1,947,393 | +546.5% | 0.14% | +625.0% |
| Q4 2016 | $3,795,000 | – | 301,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |